Search

everythinglearnresearchcommunity

for

Search:↓

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

Zinc supplements and genetic analysis help treat acrodermatitis enteropathica in children.

Early genetic testing and zinc therapy are crucial for managing acrodermatitis enteropathica in infants.

Current treatments for neutrophilic alopecias in children are limited and often ineffective, especially for males and those of Afro-Caribbean descent.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Zinc supplements effectively treat inherited zinc deficiency in infants.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Combining TCA with 5-FU is more effective and safer for treating keloids than TCA alone.

Isotretinoin is highly effective in treating severe acne, rosacea, and gram-negative folliculitis.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

New treatments for skin diseases in 1979 showed promising results with fewer side effects.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Early recognition and zinc treatment can effectively improve acrodermatitis symptoms.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Early diagnosis and lifelong zinc supplementation are crucial for treating acrodermatitis enteropathica effectively.

The formulated gel is a promising treatment for alopecia areata.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Using Cyproterone Acetate with Eflornithine together is safe and works better for treating facial hair in women.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

The AAcQLI is a promising tool for assessing quality of life in children with alopecia areata.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.